Journal article icon

Journal article

Heterozygous <i>COL17A1</i> variants are a frequent cause of amelogenesis imperfecta

Abstract:
\ua9 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.Background: Collagen XVII is most typically associated with human disease when biallelic COL17A1 variants (>230) cause junctional epidermolysis bullosa (JEB), a rare, genetically heterogeneous, mucocutaneous blistering disease with amelogenesis imperfecta (AI), a developmental enamel defect. Despite recognition that heterozygous carriers in JEB families can have AI, and that heterozygous COL17A1 variants also cause dominant corneal epithelial recurrent erosion dystrophy (ERED), the importance of heterozygous COL17A1 variants causing dominant non-syndromic AI is not widely recognised. Methods: Probands from an AI cohort were screened by single molecule molecular inversion probes or targeted hybridisation capture (both a custom panel and whole exome sequencing) for COL17A1 variants. Patient phenotypes were assessed by clinical examination and analyses of affected teeth. Results: Nineteen unrelated probands with isolated AI (no co-segregating features) had 17 heterozygous, potentially pathogenic COL17A1 variants, including missense, premature termination codons, frameshift and splice site variants in both the endo-domains and the ecto-domains of the protein. The AI phenotype was consistent with enamel of near normal thickness and variable focal hypoplasia with surface irregularities including pitting. Conclusion: These results indicate that COL17A1 variants are a frequent cause of dominantly inherited non-syndromic AI. Comparison of variants implicated in AI and JEB identifies similarities in type and distribution, with five identified in both conditions, one of which may also cause ERED. Increased availability of genetic testing means that more individuals will receive reports of heterozygous COL17A1 variants. We propose that patients with isolated AI or ERED, due to COL17A1 variants, should be considered as potential carriers for JEB and counselled accordingly, reflecting the importance of multidisciplinary care
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1136/jmg-2023-109510

Authors

More by this author
Role:
Author
ORCID:
0000-0002-4486-1625
More by this author
Role:
Author
ORCID:
0000-0003-2371-1844
More by this author
Role:
Author
ORCID:
0000-0003-3579-1079
More by this author
Role:
Author
ORCID:
0000-0001-8320-5105
More by this author
Role:
Author
ORCID:
0000-0003-3887-4451


More from this funder
Funder identifier:
10.13039/100010269
Grant:
WT093113MA
More from this funder
Funder identifier:
10.13039/501100000833
Grant:
PGS19-2/10111


Publisher:
BMJ Publishing Group
Journal:
Journal of Medical Genetics More from this journal
Volume:
61
Issue:
4
Pages:
347-355
Publication date:
2023-11-18
Acceptance date:
2023-10-17
DOI:
EISSN:
1468-6244
ISSN:
0022-2593


Language:
English
Keywords:
Pubs id:
1574126
Local pid:
pubs:1574126
Source identifiers:
W4388789409
Deposit date:
2026-06-04
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP